Submitted by Anonymous (not verified) on 4 September 2023 - 10:22
Human medicines European public assessment report (EPAR): Vumerity, diroximel fumarate, Multiple Sclerosis, Relapsing-Remitting, Date of authorisation: 15/11/2021, Revision: 4, Status: Authorised
Source: